REPROS THERAPEUTICS INC - *W EXP 02/08/201 (RPRXZ)

CUSIP: 76028H126

Q4 2014 13F Holders as of 31 Dec 2014

Type / Class
Equity / *W EXP 02/08/201
Total 13F shares
378,223
Share change
0
Total reported value
$2,058,000
Price per share
$5.14
Number of holders
3
Value change
-$697,000
Number of buys
1
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP 76028H126?
CUSIP 76028H126 identifies RPRXZ - REPROS THERAPEUTICS INC - *W EXP 02/08/201 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of REPROS THERAPEUTICS INC - *W EXP 02/08/201 (RPRXZ) as of Q4 2014

As of 31 Dec 2014, REPROS THERAPEUTICS INC - *W EXP 02/08/201 (RPRXZ) was held by 3 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 378,223 shares. The largest 3 holders included DEUTSCHE BANK AG\, SPRINGBOK CAPITAL MANAGEMENT, LLC, and UBS Group AG. This page lists 3 institutional shareholders reporting positions in this security for the Q4 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.